Lu Cai

Lu Cai practices at Lu Cai Medical in Elmhurst, New York.

Lu Cai's NPI, 1639449069, was assigned on January 2, 2012. Lu Cai holds New York license 263742.

Lu Cai's primary practice is Lu Cai Medical, at 84-25 Elmhurst Ave, Elmhurst, NY 11373 in Queens County. The practice phone is (347) 649-9131.

Lu Cai's primary practice is Lu Cai Medical in Elmhurst, New York. Dmand AI also links Lu Cai to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lu Cai practices. Vendor and product names are available with a free account.

Internal medicine is Lu Cai's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Lu Cai is licensed in New York.

CMS data shows 23 Medicare services from Lu Cai across 1 procedure code in 2024, all of them office visits, for 14 Medicare patients. Medicare paid $1,794 for them. Every service was in an office.

CMS counts 14 Medicare patients who saw Lu Cai in 2024. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Lu Cai's median patient age at 70, with 49% women.

In 2024, Lu Cai wrote 10,168 Medicare Part D claims for 314 patients. 78% of them were for generic drugs. CMS names the drug for 9,865 of them, across 107 drugs with 11 or more claims each, at $997,469 in total drug cost. In 2023, CMS named 9,260 claims across 105 drugs.

Lu Cai accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Lu Cai, published from 2011 to 2020. 2019 was the busiest year, with 2. The most frequent topics are Anesthetics, Local, Nerve Block and Pain Measurement. Lu Cai has published most often in Reg Anesth Pain Med. Lu Cai's most frequent co-authors are Nabil Mohamed Elkassabany, MD, Ignacio J. Badiola, MD and Jiabin Liu, MD, PhD.

Dmand AI links Lu Cai to 1 clinical trial. Conditions studied include Rotator Cuff Injuries and Rupture.

CMS Open Payments shows 44 general payments to Lu Cai from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $884.